Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Overview

NASDAQ:ICU - US81256L2034 - Common Stock

0.819 USD
-0.05 (-5.21%)
Last: 9/4/2025, 8:13:35 PM
0.817 USD
0 (-0.24%)
After Hours: 9/4/2025, 8:13:35 PM

ICU Key Statistics, Chart & Performance

Key Statistics
52 Week High5.79
52 Week Low0.31
Market Cap22.86M
Shares27.91M
Float27.65M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.62
PEN/A
Fwd PEN/A
Earnings (Next)11-11 2025-11-11
IPO01-26 2021-01-26
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ICU short term performance overview.The bars show the price performance of ICU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40 -50

ICU long term performance overview.The bars show the price performance of ICU in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ICU is 0.819 USD. In the past month the price increased by 2.25%. In the past year, price decreased by -83.08%.

SEASTAR MEDICAL HOLDING CORP / ICU Daily stock chart

ICU Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.1 231.15B
ISRG INTUITIVE SURGICAL INC 56.46 162.94B
BSX BOSTON SCIENTIFIC CORP 37.91 158.98B
SYK STRYKER CORP 30.69 150.76B
MDT MEDTRONIC PLC 16.79 119.10B
BDX BECTON DICKINSON AND CO 13.4 54.82B
IDXX IDEXX LABORATORIES INC 53.33 51.24B
EW EDWARDS LIFESCIENCES CORP 31.5 47.53B
RMD RESMED INC 28.67 40.09B
GEHC GE HEALTHCARE TECHNOLOGY 15.91 33.84B
DXCM DEXCOM INC 47.51 31.67B
PHG KONINKLIJKE PHILIPS NVR- NY 16.51 26.70B

About ICU

Company Profile

ICU logo image Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, Colorado and currently employs 19 full-time employees. The company went IPO on 2021-01-26. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. The company has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Company Info

SEASTAR MEDICAL HOLDING CORP

3513 Brighton Blvd, Suite 410

Denver COLORADO US

Employees: 19

ICU Company Website

ICU Investor Relations

Phone: 18444278100

SEASTAR MEDICAL HOLDING CORP / ICU FAQ

What is the stock price of SEASTAR MEDICAL HOLDING CORP today?

The current stock price of ICU is 0.819 USD. The price decreased by -5.21% in the last trading session.


What is the ticker symbol for SEASTAR MEDICAL HOLDING CORP stock?

The exchange symbol of SEASTAR MEDICAL HOLDING CORP is ICU and it is listed on the Nasdaq exchange.


On which exchange is ICU stock listed?

ICU stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SEASTAR MEDICAL HOLDING CORP stock?

5 analysts have analysed ICU and the average price target is 2.04 USD. This implies a price increase of 149.08% is expected in the next year compared to the current price of 0.819. Check the SEASTAR MEDICAL HOLDING CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SEASTAR MEDICAL HOLDING CORP worth?

SEASTAR MEDICAL HOLDING CORP (ICU) has a market capitalization of 22.86M USD. This makes ICU a Nano Cap stock.


How many employees does SEASTAR MEDICAL HOLDING CORP have?

SEASTAR MEDICAL HOLDING CORP (ICU) currently has 19 employees.


What are the support and resistance levels for SEASTAR MEDICAL HOLDING CORP (ICU) stock?

SEASTAR MEDICAL HOLDING CORP (ICU) has a resistance level at 0.9. Check the full technical report for a detailed analysis of ICU support and resistance levels.


Is SEASTAR MEDICAL HOLDING CORP (ICU) expected to grow?

The Revenue of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 509.96% in the next year. Check the estimates tab for more information on the ICU EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SEASTAR MEDICAL HOLDING CORP (ICU) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SEASTAR MEDICAL HOLDING CORP (ICU) stock pay dividends?

ICU does not pay a dividend.


When does SEASTAR MEDICAL HOLDING CORP (ICU) report earnings?

SEASTAR MEDICAL HOLDING CORP (ICU) will report earnings on 2025-11-11.


What is the Price/Earnings (PE) ratio of SEASTAR MEDICAL HOLDING CORP (ICU)?

SEASTAR MEDICAL HOLDING CORP (ICU) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.62).


What is the Short Interest ratio of SEASTAR MEDICAL HOLDING CORP (ICU) stock?

The outstanding short interest for SEASTAR MEDICAL HOLDING CORP (ICU) is 5.78% of its float. Check the ownership tab for more information on the ICU short interest.


ICU Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ICU. When comparing the yearly performance of all stocks, ICU is a bad performer in the overall market: 98.06% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ICU Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ICU. ICU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ICU Financial Highlights

Over the last trailing twelve months ICU reported a non-GAAP Earnings per Share(EPS) of -2.62. The EPS increased by 87.08% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -175.01%
ROE -439.12%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%82.52%
Sales Q2Q%N/A
EPS 1Y (TTM)87.08%
Revenue 1Y (TTM)N/A

ICU Forecast & Estimates

5 analysts have analysed ICU and the average price target is 2.04 USD. This implies a price increase of 149.08% is expected in the next year compared to the current price of 0.819.

For the next year, analysts expect an EPS growth of 90% and a revenue growth 509.96% for ICU


Analysts
Analysts80
Price Target2.04 (149.08%)
EPS Next Y90%
Revenue Next Year509.96%

ICU Ownership

Ownership
Inst Owners5.23%
Ins Owners1.29%
Short Float %5.78%
Short Ratio0.16